Skip to main content
. 2019 Jan 17;5(4):201–210. doi: 10.1159/000495909

Table 2.

The outcome of various clinical trials comparing terbinafine to griseofulvin for tinea capitis

First author Year Patients,n Country Terbinafine dose, mg/kg/day, and duration Week of therapy Cure rate,% Griseofulvin dose, mg/kg/day, and duration Cure rate, %
Deng [85] 2011 88 China 3.125–6.25 for 4 weeks 8 78.3 20 for 4 weeks 84.2
Elewski [22] 2008 1,549 International 5–8 for 4 weeks 10 45.1 10–20 for 6 weeks 39.2
Fuller [86] 2001 147 UK 3.125–6.25 for 4 weeks 12 57 10 for 8 weeks 57
Gupta [50] 2001 100 Canada and South Africa 3.125–6.25 for 2–3 weeks 12 94 20 for 6 weeks 92
Cáceres-Ríos [15] 2000 50 Peru 3.125–6.25 for 4 weeks 12 76 6.25–12.5 for 8 weeks 44
Memisoglu [87] 1999 78 Turkey 3.125–6.25 for 4 weeks 12 38.5 6.25–12.5 for 8 weeks 43.6
Haroon [88] 1995 105 Pakistan 3.125–6.25 for 4 weeks 12 92.9 6.25–12.5 for 8 weeks 79.6